ID: TP-01
Migraine is a neurological disorder that causes headaches that are often severe and throbbing. Migraines can also cause nausea, vomiting, and sensitivity to light and sound. Migraines can last for hours or days.
The global migraine drugs market size was estimated at USD 5.64 billion in 2023 and is projected to grow at a CAGR of 11.9% from 2024 to 2030. According to the WHO article published in March 2024, approximately 40% of the global population, equating to around 3.1 billion individuals, were affected by migraine and other headache disorders in 2021. [1]
A safe and eco-friendly ayurvedic formulation is available for complete sell off for treatment of migraine. The formulation aids in complete healing without any side-effects. It is useful as OTC medicine with a shelf-life of approx. 3 years. The formulation is free from any antibiotics, steroids and results in 99% and permanent healing.
[1] https://www.grandviewresearch.com/industry-analysis/migraine-drugs-market
- Patent Status: No Patent
- Options: Looking for complete sale of the technology
- Unique features: Safe, quick, no-side effects
- Stage: Trials going on
- Ask price: 15 cr
- Approvals and certifications: Received manufacturing license and Product license from Ministry of Ayush
Contact us to know more!
